| Archived Articles |
Author |
Article Date |
| Feature Articles |
New York City Companies Work toward Novel Treatments for Cancer
|
Jonathan Westring |
10/6/2006 |
New Paradigms In Successfully Crossing Borders
|
Sandra Holtzman |
10/2/2006 |
New York’s Role in the Fight Against Alzheimer’s Disease
|
Jonathan Westring |
6/23/2006 |
Nine Common Intellectual Property Mistakes Start-Up Ventures Make And How They Can Be Corrected
|
Mark Kesslen |
6/23/2006 |
Top Five Mistakes Entrepreneurs Make When Seeking Funding
|
Carlos N Velez, Ph.D. |
3/12/2006 |
NYPEN, EDC and L2WS Present “The Bioscience Cluster for the 21st Century”
|
NYPEN, EDC and L2WS |
12/6/2005 |
British Global Biotechnology Expansion
|
Jonathan Westring |
12/6/2005 |
East River Science Park
|
Monique Salazar |
9/30/2005 |
NANO, BIO and Crossing Borders
|
Sandy Holtzman |
9/20/2005 |
The Stem Cell Issue: A Look at Policy Initiatives
|
Matthew L. Wotiz, M.S. and Hakan Gadler, M.D., Ph. |
4/1/2005 |
Is the Life Science IPO Market on Life Support?
|
Hakan Gadler, M.D., Ph.D., MBA |
1/7/2005 |
Retrospective Prospicience: The NYC Biotech Cluster Revisited
|
Matthew L. Wotiz, M.S. |
11/11/2004 |
A Patent Law Perspective: Is Expedited Approval of Biogenerics Around the Corner?
|
Charles E. Cantine, Esq. and Amy E. Wilson, Ph.D. |
8/10/2004 |
Marketing Intellectual Property
|
Harry Dounchis, Ph.D. |
5/7/2004 |
| Editor's Commentary |
New Beginnings
|
Matthew L. Wotiz, M.S. |
9/30/2005 |
The Stem Cell Issue
|
Matthew L. Wotiz, M.S. |
6/1/2005 |
Licensing of Intellectual Property
|
Matthew L. Wotiz, M.S. |
5/7/2004 |
| Out Of The Lab |
HDL Platform
|
Dr. Zahi A. Fayad |
3/12/2006 |
Columbia University Technology: Crossreactive Sensor Arrays Based on DNA Receptors
|
Craig A. Kasper, Au.D. |
12/9/2005 |
Brain-derived Protein is Crucial for Survival and Growth of Blood Vessels
|
Bruce Toman |
9/20/2005 |
University at Buffalo Scientists and Sleep Solutions, Inc.
|
Michael L. Fowler, Ph.D. |
4/1/2005 |
Bringing the Grim Reaper to Cancerous Cells
|
Tari Suprapto, Ph.D. |
1/7/2005 |
Targeted T cell-mediated Immunotherapy
|
Viviane Martin, Ph.D. |
11/11/2004 |
Biomega Laboratories, Inc.
|
Andrew Koopman, M.S. |
8/10/2004 |
University at Buffalo University at Buffalo Noise-Induced Hearing Loss
|
Craig A. Kasper, Au.D. |
5/7/2004 |
| The Pitch |
Intercept Pharmaceuticals
|
Craig A. Kasper, Au.D. |
3/12/2006 |
HYWE Pharmaceuticals Inc.
|
Dr. Lan Huang |
12/6/2005 |
Gendyne Therapeutics
|
John Reilly |
8/23/2005 |
ExerGen Biosciences Inc.
|
Richard O'Rourke |
4/1/2005 |
The Pitch
|
Craig A. Kasper, Au.D. |
1/7/2005 |
Xenomics, Inc.
|
Craig A. Kasper, Au.D. |
11/11/2004 |
Kinex Pharmaceuticals
|
Craig A. Kasper, Au.D. |
8/10/2004 |
NexGenix Pharmaceuticals, LLC
|
Anjani Shah, Ph.D. |
5/7/2004 |
| Guest Commentary |
R&D Funding for NY’s Tech Companies
|
Lenzie Harcum |
6/23/2006 |
The Road Less Traveled: How Three Scientist Founders Made Successful Exits from Their Companies
|
Sandra Holtzman |
6/23/2006 |
Successful Networking: A No-Nonsense Guide to Establishing Contacts and Building Relationships in the Bioscience Arena
|
Melissa Colella |
12/6/2005 |
The Wall Street Perspective
|
Hakan Gadler |
10/1/2005 |
Broad Hollow Bioscience Park
|
Greg Blyskal |
8/23/2005 |
NYC Economic Development Corporation Commentary
|
Monique Salazar |
4/1/2005 |
The Wall Street Perspective
|
Hakan Gadler, M.D., Ph.D., MBA |
3/1/2005 |
Science City
|
Monique Salazar |
1/7/2005 |
Driving the Development of the New York State Life Sciences Community
|
Joseph Scaduto, LILSI |
1/7/2005 |
The Columbia Science and Technology Venture Program
|
Tara St. Amand, Ph.D. |
1/7/2005 |
More Power For Research Tools
|
Ihor A. Terleckyj, Ph.D. |
5/7/2004 |
| Legal Corner |
The Supreme Court’s Integra Lifesciences v Merck KGaA Decision: Adverse Effect on the Relationship between Big Pharma and Biotech?
|
Ian G. DiBernardo, Rita H. Lin and Amy E. Wilson |
12/6/2005 |
IP Issues We Care About
|
Ian G. DiBernardo, Esq. and Amy E. Wilson, Ph.D. |
6/2/2005 |
Intellectual Property Issues Surrounding Stem Cell Research
|
Ian G. DiBernardo, Esq. and Amy E. Wilson, Ph.D. |
4/1/2005 |
The Madrid Protocal and its Effects on US Trademark Applicants
|
Laura E. Goldbard and Heather L. Heft |
1/7/2005 |
The Future is Now: A Few Simple Steps to Maximize the Value of a Privately-held Business
|
Christopher Doyle |
11/11/2004 |
Implications of New U.S. - Japan Income Tax Treaty for Intellectual Property Licenses
|
L. Rosenthal,M. Bloomfield,M.Di Nunzi,I.Shainbrown |
8/10/2004 |
Understanding Taxes When Licensing Foreign-Owned Intellectual Property
|
M.W. Bloomfield,I. S. Shainbrown,M.C. Di Nunzio |
5/7/2004 |
| Creating Buzz |
One Week in Philadelphia
|
Sandra Holtzman |
4/1/2005 |
Forecastings
|
Sandra Holtzman |
1/7/2005 |
Drugs, Deals and Discovery: A View From the 800-pound Gorilla: Pfizer
|
Sandra Holtzman |
11/11/2004 |
Currents and Undercurrents
|
Sandra Holtzman |
8/10/2004 |
Tech Transfer: How It’s Done In New York State
|
S. Holtzman,S. Rabin,M.D.,J.D.,Jose Coronas |
5/7/2004 |
